Treatment of Chronic Hepatitis C Genotype 1 Patients at An Academic Center in Europe Involved in Prospective, Controlled Trials

Abstract

Baseline characteristics slightly favored study patients, but IL28B GT and treatment adherence were the most important factors determining outcome. Thus, the applicability of the results of controlled studies has to be tested in a "real-world" setting.